Our Product Liability team, named PL Group of the Year by Law360 in 2016, for the fourth consecutive year, leverages knowledge of the complex science and technology behind today’s products to deliver litigation victories. Over the past decade, we have handled numerous class actions, nearly all dismissed or effectively resolved at relatively early stages and on terms favorable to our clients. We are one of a few firms in the U.S. to have tried class action lawsuit to verdict.
Drawing on capabilities in FDA regulatory, e-discovery, government investigations and appellate, as needed, our Product Liability team deploys first-chair trial resources, serving as national coordinating and regional counsel for pharmaceutical and medical device, energy, chemical, automotive, consumer products, and food and beverage companies. Nationwide, we represent clients in individual, class action, and coordinated/mass tort cases at the trial and appellate levels, including in the most difficult U.S. jurisdictions.
Four fellows of the American College of Trial Lawyers are counted among the team. We also field lawyers and scientific consultants who focus on the scientific and regulatory aspects of tort litigation, led by cardiologist and former Harvard Professor of Medicine Dr. Beverly Lorell. These specialists identify and prepare medical and scientific expert witnesses and strategically challenge plaintiffs’ experts.
The team’s 2016 Law360 Group of the Year award contributed to King & Spalding’s being named 2016 Firm of the Year by the same publication, with top group honors also going to our Life Sciences and International Arbitration teams, among others.
Product Liability Practice Group of the Year, 2013–2017 — Law 360Read More
June 15, 2017
High Court's Superficial Analysis In Biosimilars Ruling